Skip to content

INCY

Incyte Corporation

NASDAQ · USHealthcareBiotechnology
$115.65-1.36%

Price as of Jul 20, 2026

INCY capital

Incyte Corporation capital & dividend

Leverage, liquidity, debt coverage and shareholder-distribution metrics.

Leverage

Debt / equity
0.01x
Net debt / equity
-0.62x
Debt / assets
0.00x
Debt / EBITDA
0.02x
Net debt / EBITDA
-1.83x

Liquidity & coverage

Current ratio
3.68x
Quick ratio
3.60x
Cash ratio
2.70x
Interest coverage
620.56x
EBITDA / interest
800.57x
Working capital
$4.0B

Cash & dividend

FCF / debt
42.89x
Cash flow / debt
44.84x
Dividend per share
Dividend yield
Dividend growth 1y

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.